The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli

Infection and Immunity

Volumn 80, Issue 6, 2012, Pages 2042-2052

  Baldi, Deborah L ^a   Higginson, Ellen E ^a   Hocking, Dianna M ^a   Praszkier, Judyta ^a,e   Cavaliere, Rosalia ^b   James, Catherine E ^b   Bennett Wood, Vicki ^a   Azzopardi, Kristy I ^a,c   Turnbull, Lynne ^b   Lithgow, Trevor ^d   Robins Browne, Roy M ^a,c   Whitchurch, Cynthia B ^b   Tauschek, Marija ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROTOXIN; LIPOPROTEIN; LIPOPROTEIN SSLE; OUTER MEMBRANE PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; MUTATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TYPE II SECRETION SYSTEM; WILD TYPE; ANIMAL; CELL MEMBRANE; CYTOLOGY; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANIMALS; BIOFILMS; CELL MEMBRANE; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; MUTATION; RABBITS; SUBSTRATE SPECIFICITY; VIRULENCE;

EID: 84863836580     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06160-11     Document Type: Article

References (69)

1. Abe A, Heczko U, Hegele RG, Brett Finlay B. 1998. Two enteropathogenic Escherichia coli type III secreted proteins, EspA and EspB, are virulence factors. J. Exp. Med. 188:1907-1916.
2. Adams LM, Simmons CP, Rezmann L, Strugnell RA, Robins-Browne RM. 1997. Identification and characterization of a K88- and CS31A-like operon of a rabbit enteropathogenic Escherichia coli strain which encodes fimbriae involved in the colonization of rabbit intestine. Infect. Immun. 65:5222-5230.
3. Anderson GG, Dodson KW, Hooton TM, Hultgren SJ. 2004. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol. 12:424-430.
4. Anderson GG, et al. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107.
5. Athanasopoulos V, Praszkier J, Pittard AJ. 1995. The replication of an IncL/M plasmid is subject to antisense control. J. Bacteriol. 177:4730- 4741.
6. Ball G, Durand E, Lazdunski A, Filloux A. 2002. A novel type II secretion system in Pseudomonas aeruginosa. Mol. Microbiol. 43:475- 485.
7. Bartolome B, Jubete Y, Martinez E, de la Cruz F. 1991. Construction and properties of a family of pACYC184-derived cloning vectors compatible with pBR322 and its derivatives. Gene 102:75-78.
8. Bolivar F, et al. 1977. Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2:95-113.
9. Brzuszkiewicz E, et al. 2006. How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains. Proc. Natl. Acad. Sci. U. S. A. 103:12879 -12884.
10. Casadaban MJ. 1976. Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J. Mol. Biol. 104:541-555.
11. Chalker AF, et al. 2001. Systematic identification of selective essential genes in Helicobacter pylori by genome prioritization and allelic replacement mutagenesis. J. Bacteriol. 183:1259 -1268.
12. Chang AC, Cohen SN. 1978. Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J. Bacteriol. 134:1141-1156.
13. Chaudhuri RR, et al. 2010. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One 5:e8801.
14. Chen SL, et al. 2006. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. Proc. Natl. Acad. Sci. U. S. A. 103:5977-5982.
15. Clements A, et al. 2009. The reducible complexity of a mitochondrial molecular machine. Proc. Natl. Acad. Sci. U. S. A. 106:15791-15795.
16. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
17. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318 -1322.
18. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
19. Dean P, Kenny B. 2009. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr. Opin. Microbiol. 12:101-109.
20. de Castro E, et al. 2006. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res. 34:W362-W365.
21. Elliott SJ, et al. 1998. The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28:1- 4.
22. Evans DG, Evans DJ, Jr, Pierce NF. 1973. Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect. Immun. 7:873- 880.
23. Evans DJ, Jr, Evans DG, Gorbach SL. 1973. Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man. Infect. Immun. 8:725-730.
24. Francetic O, Belin D, Badaut C, Pugsley AP. 2000. Expression of the endogenous type II secretion pathway in Escherichia coli leads to chitinase secretion. EMBO J. 19:6697- 6703.
25. Frankel G, et al. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 30:911-921.
26. Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 177:4121- 4130.
27. Hall-Stoodley L, Costerton JW, Stoodley P. 2004. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2:95-108.
28. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell. Microbiol. 11:1034 -1043.
29. Herring CD, Glasner JD, Blattner FR. 2003. Gene replacement without selection: regulated suppression of amber mutations in Escherichia coli. Gene 311:153-163.
30. Heydorn A, et al. 2000. Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 146:2395-2407.
31. Ho TD, Davis BM, Ritchie JM, Waldor MK. 2008. Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization. Infect. Immun. 76:1858 -1865.
32. Iguchi A, et al. 2009. Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/J. Bacteriol. 191:347-354.
33. Johnson TJ, et al. 2007. The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J. Bacteriol. 189:3228 -3236.
34. Johnson TL, Abendroth J, Hol WG, Sandkvist M. 2006. Type II secretion: from structure to function. FEMS Microbiol. Lett. 255:175-186.
35. Juncker AS, et al. 2003. Prediction of lipoprotein signal peptides in Gramnegative bacteria. Protein Sci. 12:1652-1662.
36. Knutton S, Baldwin T, Williams PH, McNeish AS. 1989. Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 57:1290 -1298.
37. Kornacker MG, Boyd A, Pugsley AP, Plastow GS. 1989. Klebsiella pneumoniae strain K21: evidence for the rapid secretion of an unacylated form of pullulanase. Mol. Microbiol. 3:497-503.
38. Kulkarni R, et al. 2009. Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli. PLoS One 4:e4752.
39. Lathem WW, et al. 2002. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol. Microbiol. 45:277-288.
40. Levine MM, et al. 1978. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet i:1119 -1122.
41. Long-Krug SA, et al. 1984. Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits? Infect. Immun. 46:612- 614.
42. Marches O, et al. 2000. Role of Tir and intimin in the virulence of rabbit enteropathogenic Escherichia coli serotype O103:H2. Infect. Immun. 68: 2171-2182.
43. Michaelis S, Chapon C, D'Enfert C, Pugsley AP, Schwartz M. 1985. Characterization and expression of the structural gene for pullulanase, a maltose-inducible secreted protein of Klebsiella pneumoniae. J. Bacteriol. 164:633- 638.
44. Miller JH. 1974. Experiments in molecular genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
45. Mohamed JA, et al. 2007. Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. J. Clin. Microbiol. 45:121-126.
46. Moreira CG, et al. 2006. Bundle-forming pili and EspA are involved in biofilm formation by enteropathogenic Escherichia coli. J. Bacteriol. 188: 3952-3961.
47. Moriel DG, et al. 2010. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 107:9072-9077.
48. Nouwen N, et al. 1999. Secretin PulD: association with pilot PulS, structure, and ion-conducting channel formation. Proc. Natl. Acad. Sci. U. S. A. 96:8173- 8177.
49. Ogura Y, et al. 2009. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 106:17939 -17944.
50. Peterson KM, Mekalanos JJ. 1988. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect. Immun. 56:2822-2829.
51. Posfai G, Koob MD, Kirkpatrick HA, Blattner FR. 1997. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J. Bacteriol. 179:4426-4428.
52. Pugsley AP. 1993. The complete general secretory pathway in gramnegative bacteria. Microbiol. Rev. 57:50 -108.
53. Py B, Loiseau L, Barras F. 1999. Assembly of the type II secretion machinery of Erwinia chrysanthemi: direct interaction and associated conformational change between OutE, the putative ATP-binding component and the membrane protein OutL. J. Mol. Biol. 289:659-670.
54. Rasko DA, et al. 2008. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J. Bacteriol. 190:6881- 6893.
55. Robins-Browne RM. 1987. Traditional enteropathogenic Escherichia coli of infantile diarrhea. Rev. Infect. Dis. 9:28 -53.
56. Robins-Browne RM, Levine MM, Rowe B, Gabriel EM. 1982. Failure to detect conventional enterotoxins in classical enteropathogenic (serotyped) Escherichia coli strains of proven pathogenicity. Infect. Immun. 38:798-801.
57. Sambrook J, Russell DW. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Sandkvist M. 2001. Biology of type II secretion. Mol. Microbiol. 40:271- 283.
59. Sandkvist M, et al. 1997. General secretion pathway (eps) genes required for toxin secretion and outer membrane biogenesis in Vibrio cholerae. J. Bacteriol. 179:6994 -7003.
60. Sikora AE, Lybarger SR, Sandkvist M. 2007. Compromised outer membrane integrity in Vibrio cholerae type II secretion mutants. J. Bacteriol. 189:8484-8495.
61. Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM. 2002. Identification of a protein secretory pathway for the secretion of heatlabile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 99:7066 -7071.
62. Tauschek M, et al. 2010. Transcriptional analysis of the grlRA virulence operon from Citrobacter rodentium. J. Bacteriol. 192:3722-3734.
63. Touchon M, et al. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet. 5:e1000344.
64. Udekwu KI, Wagner EG. 2007. Sigma E controls biogenesis of the antisense RNA MicA. Nucleic Acids Res. 35:1279 -1288.
65. Vignon G, et al. 2003. Type IV-like pili formed by the type II secreton: specificity, composition, bundling, polar localization, and surface presentation of peptides. J. Bacteriol. 185:3416 -3428.
66. Voulhoux R, et al. 2001. Involvement of the twin-arginine translocation system in protein secretion via the type II pathway. EMBO J. 20:6735- 6741.
67. Yang J, Baldi DL, Tauschek M, Strugnell RA, Robins-Browne RM. 2007. Transcriptional regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM cluster, encoding the type II secretion pathway in enterotoxigenic Escherichia coli. J. Bacteriol. 189:142-150.
68. Yang J, Tauschek M, Strugnell R, Robins-Browne RM. 2005. The H-NS protein represses transcription of the eltAB operon, which encodes heatlabile enterotoxin in enterotoxigenic Escherichia coli, by binding to regions downstream of the promoter. Microbiology 151:1199 -1208.
69. Zhu C, Feng S, Thate TE, Kaper JB, Boedeker EC. 2006. Towards a vaccine for attaching and effacing Escherichia coli: a LEE encoded regulator (ler) mutant of rabbit enteropathogenic Escherichia coli is attenuated, immunogenic, and protects rabbits from lethal challenge with the wild-type virulent strain. Vaccine 24:3845-3855.